Clinical Study

P-Cresyl Sulfate Is a Valuable Predictor of Clinical Outcomes in Pre-ESRD Patients

Table 3

Univariate and multivariate Cox regression analysis for evaluating the relationship between independent variables and clinical outcomes in CKD patients.

VariablesCardiovascular eventAll-cause mortalityDialysis
Univariate Cox regression analysis Multivariate Cox regression analysis Univariate Cox regression analysis Univariate Cox regression analysis Multivariate Cox regression analysis
HR95% CI HR95% CI HR95% CI HR95% CI HR95% CI

Gender (F/M)0.660.24–1.77NS0.840.12–5.99NS0.80 0.29–2.21NS
Age (years)1.081.01–1.150.011.121.00–1.250.011.120.95–1.30 NS0.930.89–0.98<0.010.910.85–0.96<0.01
CV/Non-CV2.921.01–8.410.046.281.32–29.71 0.020.040.00–31.81NS0.720.16–3.19NS
DM/Non-DM1.80 0.67–4.83NS2.190.31–15.58NS0.520.14–1.84NS
BUN (mg/dL)1.031.00–1.04<0.010.980.95–1.03NS0.990.94–1.03NS1.051.02–1.07<0.010.990.95–1.03NS
Cr (mg/dL)1.110.97–1.28NS0.890.56–1.41NS1.511.31–1.73<0.011.250.74–2.11NS
eGFR (mL/min)0.950.91–0.99<0.010.990.93–1.06NS0.980.92–1.05NS0.80 0.71–0.90 <0.010.690.47–1.02NS
Hb (g/dL)0.850.82–1.93NS0.790.56–1.04NS0.850.33–2.31NS
Hct (%)0.90 0.33–2.42NS3.770.39–36.31NS0.910.82–1.01NS
Albumin (g/dL)0.820.25–2.65NS0.850.06–10.82NS0.390.15–0.990.040.030.00–0.33<0.01
Ca (mg/dL)0.270.11–0.65<0.010.540.19–1.54NS3.290.44–24.11NS0.410.15–1.10 NS
P (mg/dL)1.971.16–3.330.011.660.70–3.91NS0.410.08–2.02NS2.061.15–3.720.010.930.53–1.02NS
i-PTH (pg/mL)1.00 1.00-1.00 0.031.00 0.99–1.01 NS1.00 0.99–1.01NS1.00 1.00-1.00 <0.010.990.99-1.00 NS
PCS (mg/L)1.081.02–1.15<0.011.12 1.01–1.210.021.060.94–1.21NS1.10 1.02–1.17<0.011.171.05–1.30 <0.01

PCS: P-cresyl sulfate, NS: no significance, CI: confidence interval.